Sort
48,018 grants matching “immunotherapy”
Lab Research Training in Pediatric Oncology-Hematology
$666,679Alan D Friedman · Johns Hopkins University · T32 · FY2025 · CA
Transcriptional Regulation of human natural killer cell function
$666,567Timothy E O'Sullivan · University Of California Los Angeles · R01 · FY2025 · AI
Mechanism of cell uptake for pathogenic tau seeds
$666,475Marc I Diamond · Ut Southwestern Medical Center · R01 · FY2025 · AG
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$666,466Diane M Simeone · New York University School Of Medicine · R01 · FY2022 · CA
CANCER AND LEUKEMIA GROUP B
$666,421Brigham And Women'S Hospital · U10 · FY2001 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$666,397Andre Rogatko · Cedars-Sinai Medical Center · U01 · FY2020 · CA
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials
$666,397Mourad Tighiouart · Cedars-Sinai Medical Center · U01 · FY2021 · CA
Immune correlates of acute HBV recovery with and without HIV
$666,387Chloe L Thio · Johns Hopkins University · R01 · FY2016 · AI
Nanotherapeutic strategies for the treatment of chronic Chagas Disease
$666,319Evan Alexander Scott · University Of Virginia · R01 · FY2025 · HL
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$666,296Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapy
$666,104Youngho Seo · University Of California, San Francisco · R01 · FY2024 · HL
Alpha-Emitter Therapy of Osteosarcoma
$666,045Dara L Kraitchman · Johns Hopkins University · R01 · FY2025 · CA
Molecular Allergy
$666,036Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$665,918Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
An urinary drug disposing approach for treatment of bladder Cancer
$665,916Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$665,907Mark Larche · Mcmaster University · U19 · FY2016 · AI
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
$665,878Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2021 · CA
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$665,841Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$665,839Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Clinical evaluation of IL13Ra2-targeted CAR T cell therapy in combination with nivolumab in patients with recurrent malignant glioma
$665,839Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer
$665,617Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
$665,532Catherine Sibyl Diefenbach · New York University School Of Medicine · R01 · FY2024 · CA
Dissecting the role of CD8+ T cells in atherosclerosis
$665,467Chiara Giannarelli · New York University School Of Medicine · R01 · FY2023 · HL
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$665,456Meghan E. Sise · Massachusetts General Hospital · R01 · FY2025 · DK
Determinants of toxicity and response to immune checkpoint blockade through integrative profiling of T cell clonal dynamics and plasma cell- free DNA
$665,413Aadel Chaudhuri · Mayo Clinic Rochester · R01 · FY2025 · CA